Edition:
United States

Imprimis Pharmaceuticals Inc (IMMY.OQ)

IMMY.OQ on NASDAQ Stock Exchange Capital Market

3.03USD
17 Aug 2018
Change (% chg)

$0.08 (+2.71%)
Prev Close
$2.95
Open
$2.95
Day's High
$3.08
Day's Low
$2.89
Volume
35,482
Avg. Vol
23,954
52-wk High
$3.38
52-wk Low
$1.35

Chart for

About

Imprimis Pharmaceuticals, Inc. (Imprimis) is engaged in the development, production and dispensing of compounded pharmaceuticals. The Company operates through the business of developing drug therapies and providing such therapies through sterile and non-sterile pharmaceutical compounding services segment. The Company, through... (more)
No analyst recommendations are available for .

Overall

Beta: -0.53
Market Cap(Mil.): $63.78
Shares Outstanding(Mil.): 21.05
Dividend: --
Yield (%): --

Financials

  IMMY.OQ Industry Sector
P/E (TTM): -- 99.36 30.45
EPS (TTM): -0.47 -- --
ROI: -46.98 2.89 12.63
ROE: -166.18 1.65 14.82

BRIEF-Imprimis Pharmaceuticals Q1 Revenue Rose 45 Pct To $8.9 Million

* IMPRIMIS PHARMACEUTICALS ANNOUNCES FIRST QUARTER 2018 RESULTS

May 15 2018

BRIEF-Surface Pharmaceuticals, Inc. Announces $20 Million Series A Financing From Flying L Partners

* SURFACE PHARMACEUTICALS, INC. ANNOUNCES $20 MILLION SERIES A FINANCING FROM FLYING L PARTNERS

May 15 2018

BRIEF-Imprimis Pharmaceuticals Issued Composition Patent For Non-Opioid Conscious Sedation Formulation

* IMPRIMIS PHARMACEUTICALS ISSUED COMPOSITION PATENT FOR NON-OPIOID CONSCIOUS SEDATION FORMULATION

Mar 27 2018

BRIEF-Imprimis Pharmaceuticals Q4 Revenue $7.3 Million

* IMPRIMIS PHARMACEUTICALS ANNOUNCES FOURTH QUARTER 2017 RESULTS

Mar 08 2018

Competitors

  Price Chg
Eli Lilly And Co (LLY.N) $105.55 +1.19
Sanofi SA (SASY.PA) €73.30 +0.64
Bayer AG (BAYGn.DE) €78.40 +1.35
Bayer AG (BAYE.F) -- --
Roche Holding Ltd. (ROG.S) CHF239.95 +0.75
Roche Holding Ltd. (RO.S) CHF243.20 +0.20
Merck & Co., Inc. (MRK.N) $69.06 +0.21
Novartis AG (NOVN.S) CHF82.48 +0.76

Earnings vs. Estimates